David Duncan – University of California, Berkeley

David’s the author of the “Experimental Man”, and “When I’m 164”, about the new science of radical life extension and what happens if it succeeds. He’s also the Chief Correspondent of public radio’s Biotech Nation; and a columnist for Fortune. Oh, and he also runs the Personalized Health Project and Summit.

The Frontier of Health 2.0

David Ewing Duncan returned to the 8th Annual Fall Conference to explore the future of how health and care delivery will begin to be customized to the patient via genomics, robotics, 3D printing tools, and other sensors.

Body 2.0 Keynote: Dr. Arlene Blum – “Breaking Trail, A Climbing Life”

Arlene Blum PhD, biophysical chemist, author, and mountaineer is a Visiting Scholar at UC Berkeley’s Department of Chemistry and executive director of the Green Science Policy Institute. Her research and policy work has contributed to preventing the use toxic flame retardants from children’s sleepwear, electronics, and other products. She has taught chemistry at Stanford University, Wellesley College, and U. C. Berkeley. (more…)

The Future of Personalized Health: UC Berkeley

David’s the author of the Experimental Man, and When I’m 164 about the new science of radical life extension, and what happens if it succeeds. He’s also the Chief Correspondent of public radio’s Biotech Nation; and a columnist for Fortune. Oh, and he also runs the Personalized Health Project and Summit.

The Future of Personalized Health

The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?

thumbnail_2_7d5b3486_2_v1

David Duncan – University of California, Berkeley

David’s the author of the “Experimental Man”, and “When I’m 164”, about the new science of radical life extension and what happens if it succeeds. He’s also the Chief Correspondent of public radio’s Biotech Nation; and a columnist for Fortune. Oh, and he also runs the Personalized Health Project and Summit.

thumbnail_2_f4b4ac7e_1_v1

The Frontier of Health 2.0

David Ewing Duncan returned to the 8th Annual Fall Conference to explore the future of how health and care delivery will begin to be customized to the patient via genomics, robotics, 3D printing tools, and other sensors.

bodyarlene

Body 2.0 Keynote: Dr. Arlene Blum – “Breaking Trail, ...

Arlene Blum PhD, biophysical chemist, author, and mountaineer is a Visiting Scholar at UC Berkeley’s Department of Chemistry and executive director of the Green Science Policy Institute. Her research and policy work has contributed to preventing the use toxic flame retardants from children's sleepwear, electronics, and other products. She has taught chemistry at Stanford University, Wellesley College, and U. C. Berkeley.
fopberk

The Future of Personalized Health: UC Berkeley

David’s the author of the Experimental Man, and When I’m 164 about the new science of radical life extension, and what happens if it succeeds. He’s also the Chief Correspondent of public radio’s Biotech Nation; and a columnist for Fortune. Oh, and he also runs the Personalized Health Project and Summit.

fop

The Future of Personalized Health

The tools, devices, sensors and other technologies that will be used to collect and monitor health data and customize it to the user. Going forward, how will genomics, robotics and behavior change fit into personalized health?